UNH

Unitedhealth Group
D

UNH

Arincen63/100B
409.28
USD
5.31
(1.31%)
Post Trading·411.20USD+1.92(+0.47%)
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 2.28Revenue estimate 112.26B
OverviewFinancialsSignalsNewsForecastEarningsDividendsCompany

Unitedhealth Group revenue 1985–2026

Unitedhealth Group's revenue in Q3 FY2026, the three months to 30 September 2026, was 112.69B USD, down 0.4% on the same quarter a year before. Unitedhealth Group's revenue over the last twelve months was 449.66B USD, up 3.3% on the twelve months before. In fiscal year 2025 it was 447.57B USD, up 11.8% on the year before.

Last updated 4 Nov 2026 · Next report 20 Jan 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 2026449.66B+3.33%102.58B15.88B
FY202531 Dec 2025447.57B+11.81%82.92B12.06B
FY202431 Dec 2024400.28B+7.71%89.40B14.41B
FY202331 Dec 2023371.62B+14.64%90.96B22.38B
FY202231 Dec 2022324.16B+12.71%79.62B20.12B
FY202131 Dec 2021287.60B+11.84%69.65B17.29B
FY202031 Dec 2020257.14B+6.19%67.00B15.40B
FY201931 Dec 2019242.16B+7.03%57.60B13.84B
FY201831 Dec 2018226.25B+12.47%53.85B11.99B
FY201731 Dec 2017201.16B+8.83%47.01B10.56B
FY201631 Dec 2016184.84B+17.65%43.39B7.02B
FY201531 Dec 2015157.11B+20.41%37.03B5.81B
FY201431 Dec 2014130.47B+6.52%33.43B5.62B
FY201331 Dec 2013122.49B+10.73%30.36B5.63B
FY201231 Dec 2012110.62B+8.60%27.87B5.53B
FY201131 Dec 2011101.86B+8.19%9.59B5.14B
FY201031 Dec 201094.16B+8.05%8.93B4.63B
FY200931 Dec 200987.14B+7.33%7.35B3.82B
FY200831 Dec 200881.19B+7.63%19.35B2.98B
FY200731 Dec 200775.43B+5.44%19.23B4.65B
FY200631 Dec 200671.54B+54.08%16.76B4.16B
FY200531 Dec 200546.43B+24.76%12.14B3.08B
FY200431 Dec 200437.22B+30.29%-28.64B2.59B
FY200331 Dec 200328.57B+14.17%7.85B1.66B
FY200231 Dec 200225.02B+6.68%6.83B1.35B
FY200131 Dec 200123.45B+11.04%1.83B913.00M
FY200031 Dec 200021.12B+7.97%4.97B736.00M
FY199931 Dec 199919.56B+12.72%4.52B568.00M
FY199831 Dec 199817.36B+47.15%3.83B-166.00M
FY199731 Dec 199711.79B+17.08%3.25B460.00M
FY199631 Dec 199610.07B+77.64%2.89B355.64M
FY199531 Dec 19955.67B+50.47%1.74B285.96M
FY199431 Dec 19943.77B+49.13%1.13B1.67B
FY199331 Dec 19932.53B+75.29%764.70M194.60M
FY199231 Dec 19921.44B+70.20%482.60M114.20M
FY199131 Dec 1991847.10M+39.90%313.40M74.80M
FY199031 Dec 1990605.50M+46.97%221.80M33.90M
FY198931 Dec 1989412.00M-5.05%168.40M13.70M
FY198831 Dec 1988433.90M-0.34%129.20M-36.80M
FY198731 Dec 1987435.40M+104.51%136.90M-15.80M
FY198631 Dec 1986212.90M+110.38%89.80M6.30M
FY198531 Dec 1985101.20M—49.00M2.10M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Unitedhealth Group revenue growth by segment

Q3 FY2026 against Q3 FY2025

Unitedhealthcare83.03B
-4.6%
Optumhealth4.05B
-84.4%

Unitedhealth Group revenue by segment over time

Premiums Products Services Investment and other income Optumrx Optumhealth Optuminsight Unitedhealthcare Intersegment Eliminations
Fiscal yearPremiumsProductsServicesInvestment and other incomeOptumrxOptumhealthOptuminsightUnitedhealthcareIntersegment Eliminations
FY2025352.23B 53.38B 38.04B 3.92B — — — — —
FY2024— — — — 133.23B 105.36B 18.76B 298.21B -150.89B
FY2022— — — — 99.77B +9.3%71.17B +31.6%14.58B +19.5%249.74B +12.0%-108.35B
FY2021— — — — 91.31B +4.4%54.07B +35.8%12.20B +12.9%222.90B +11.0%-90.87B
FY2020— — — — 87.50B +17.8%39.81B +31.3%10.80B +8.0%200.88B +3.6%-80.04B
FY2019— — — — 74.29B +6.8%30.32B +25.6%10.01B +11.1%193.84B +5.6%-64.64B
FY2018— — — — 69.54B +9.1%24.15B +17.4%9.01B +11.4%183.48B +12.4%-58.51B
FY2017— — — — 63.76B +5.5%20.57B +21.7%8.09B +10.3%163.26B +9.9%-53.28B
FY2016— — — — 60.44B +25.2%16.91B +21.4%7.33B +18.4%148.58B +13.1%-47.33B
FY2015— — — — 48.27B 13.93B 6.20B 131.34B -41.84B

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Unitedhealth Group's revenue

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.